NovMetaPharma Co (XKRX:229500) Total Inventories : ₩18.48 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is NovMetaPharma Co Total Inventories?

NovMetaPharma Co's total inventories for the quarter that ended in Dec. 2023 was ₩18.48 Mil. NovMetaPharma Co's average total inventories from the quarter that ended in Dec. 2022 to the quarter that ended in Dec. 2023 was ₩21.91 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. NovMetaPharma Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was ₩202.62.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. NovMetaPharma Co's Days Inventory for the six months ended in Dec. 2023 was 629.03.

Inventory Turnover measures how fast the company turns over its inventory within a year. NovMetaPharma Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.29.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. NovMetaPharma Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.58.

NovMetaPharma Co Total Inventories Historical Data

The historical data trend for NovMetaPharma Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovMetaPharma Co Total Inventories Chart

NovMetaPharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

43.97

7.26

40.65

25.34

18.48

NovMetaPharma Co Semi-Annual Data
	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Total Inventories	Get a 7-Day Free Trial				43.97	7.26	40.65	25.34	18.48

NovMetaPharma Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

NovMetaPharma Co (XKRX:229500) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

NovMetaPharma Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(5822.454	+	0.75 * 0	+	0.5 * 18.482	-	3713.547
-	0	-	0)	/	10.454
=	202.62

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

NovMetaPharma Co's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	21.911	/	6.357	*	365 / 2
	=	629.03

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

NovMetaPharma Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	6.357	/	21.911
	=	0.29

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

NovMetaPharma Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	21.911	/	13.851
	=	1.58

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

NovMetaPharma Co Total Inventories Related Terms

Thank you for viewing the detailed overview of NovMetaPharma Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

NovMetaPharma Co (XKRX:229500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NovMetaPharma Co Ltd (XKRX:229500) » Definitions » Total Inventories

Traded in Other Exchanges

N/A

Address

727 13, Gangnam-gu, Seoul eonju layer, Seoul, KOR

Website

http://www.novmeta.com

NovMetaPharma Co Ltd researches and develops new medicines and health supplements for metabolic diseases. The company is developing a therapeutic agent that is in Phase 2a clinical trial for Type 2 diabetes and obesity. It also develops therapeutic agents for Alzheimer's disease, immune system diseases, osteoporosis, and non-alcoholic fatty liver diseases.

NovMetaPharma Co (XKRX:229500) Headlines

No Headlines